Solomon Carter Fuller, M.D. (1872-1953): American Pioneer in Alzheimer’s Disease Research

@article{Kaplan2000SolomonCF,
  title={Solomon Carter Fuller, M.D. (1872-1953): American Pioneer in Alzheimer’s Disease Research},
  author={Mary Kaplan and Anthony R. Henderson},
  journal={Journal of the History of the Neurosciences},
  year={2000},
  volume={9},
  pages={250 - 261}
}
The appointment of Alois Alzheimer to Emil Kraepelin’s clinic and laboratory at the Royal Psychiatric Hospital, University of Munich in 1903 offered new opportunities for clinical and pathological studies of the brain. At the opening of the facility in 1904, Alzheimer selected five foreign visiting students as his graduate research assistants, among whom was an American, Dr. Solomon Carter Fuller. A glimpse of Fuller’s background as an African-American (born in Liberia) at the turn of the… Expand
Recognizing African‐American contributions to neurology: The role of Solomon Carter Fuller (1872–1953) in Alzheimer's disease research
  • H. Mohammed
  • Medicine, Psychology
  • Alzheimer's & dementia : the journal of the Alzheimer's Association
  • 2020
TLDR
Dr Fuller was the first to translate much of Alzheimer's pivotal work into English, including that of Auguste Deter, the first reported case of the disease, in it reporting the ninth case ever described. Expand
Homeopathy and the Mind: From Alienists to Neuroscientists
Hahnemann adopted unusually humane measures in treating the mentally ill, and his system gave rise to a nationwide network of homeopathic asylums in the United States. This chapter reviews theExpand
History of dementia.
  • F. Boller
  • Psychology, Medicine
  • Handbook of clinical neurology
  • 2008
Publisher Summary In the beginning of the 20th century, a series of neurological and neuropathological breakthroughs were seen in the field of dementia. The chapter reviews some of the early centralExpand
The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics.
TLDR
An amyloid-agnostic approach is necessary to discover therapeutics for age-related dementias as well as to focus efforts and funding in dementia-related research. Expand
Alzheimer's disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
TLDR
This Commentary discusses amyloid and tau as putative drug targets for AD in the context of the prevalence and economic and social impact of this insidious neurodegenerative disease. Expand
Alzheimer's disease beyond amyloid: can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Alzheimer's Disease (AD) therapeutics based on the amyloid hypothesis have repeatedly failed in clinical trials. Together with numerous reports that amyloid is present in brains from aged individualsExpand
They have Shaped Alzheimer Disease the Protagonists, Well Known and Less Well Known
TLDR
The history of dementia and Alzheimer's disease with emphasis on the individuals who have shaped its development are discussed, including the best known protagonists recognized as founders of the field. Expand
The Madrid School of Neurology (1885-1939).
TLDR
The emergence of neurology in Madrid between 1885 and 1939 had well-defined characteristics and pioneers combined clinical practice with cutting-edge neurohistology and neuropathology research, including the first cluster of Huntington's disease in Spain. Expand

References

SHOWING 1-10 OF 32 REFERENCES
Origin of the distinction between Alzheimer's disease and senile dementia
TLDR
History reveals that the distinction between presenile (Alzheimer's disease) and senile dementia was originally based on anecdotal clinical observations and that competition among universities was one of the underlying determinants. Expand
On certain peculiar diseases of old age
TLDR
Alois Alzheimer presented the famous case of the disease which bears his name in 1906 at a meeting of the Southwest German Psychiatrists and in 1910 Kraepelin gave the disease its eponymous title. Expand
The Founders of Neurology
TLDR
Will Pickles was a country general practitioner of Wensleydale, who made a positive contribution to epidemiology, defining the incubation periods of infectious fevers by a method which he described as 'the short and only possible contact'. Expand
A STUDY OF THE MILIARY PLAQUES FOUND IN BRAINS OF THE AGED
The central point of this study has been the miliary plaques commonly found in the brains of persons dying at an advanced age. Consideration, however, has been given many other factors which mightExpand
Research in the United States
TLDR
America now leads hi hydrocarbon research, the world order being now : United States first, Germany second, Russia third and Great Britain fourth. Expand
A History of American Pathology
TLDR
Books and internet are the recommended media to help you improving your quality and performance. Expand
Centerscope. Boston, Boston University School of Medicine, Winter Edition: 26-30
  • 1976
A study of the neurofibrils of demented paralytic, demented senilis, chronic alcoholics, cerebro lues and microcephalics
  • Amer J Insanity
  • 1907
Further observations on Alzheimer’s disease
  • Am J Insanity
  • 1912
The first Alzheimer diagnosis
  • confirmed. Science:
  • 1998
...
1
2
3
4
...